417
Participants
Start Date
November 21, 2018
Primary Completion Date
August 5, 2024
Study Completion Date
August 5, 2024
Placebo
Volume equivalent to 1200 mg of atezolizumab drug product. Intravenous Day 1
Carboplatin
Intravenous. Day 1
Paclitaxel
175 mg/m². Intravenous. Day 1
Niraparib
200 mg or 300 mg. Oral. From day 1 to 21
Gemcitabine
1000 mg/m². Intravenous. Day 1 and day 8.
Pegylated liposomal doxorubicin (PLD)
30 mg/m². Intravenous. Day 1
Atezolizumab
1200 mg. Intravenous. Day 1
Institut Paoli Calmettes, Marseille
Centre François Baclesse, Caen
HPCA Cario, Plérin
CHU Besançon, Besançon
ONCOGARD - Institut de Cancérologie du Gard, Nîmes
Clinica Universidad de Navarra, Pamplona
Institut Bergonié, Bordeaux
ICM Val d'Aurelle, Montpellier
ICO Centre René Gauducheau, Saint-Herblain
ICO - Paul Paupin - ANGERS, Angers
Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy
Centre Jean Perrin, Clermont-Ferrand
Universitätsklinikum Mannheim, Mannheim
Centre Léon Bérard, Lyon
Hôpital Cochin, Paris
Hôpital Européen Georges Pompidou, Paris
Groupe Hospitalier Diaconesses-Croix Saint Simon, Paris
Hôpital Tenon, Paris
Institut Curie - Hopital Claudius Régaud, Saint-Cloud
Institut Curie - Hôpital René Huguenin- SAINT CLOUD, Saint-Cloud
Gustave Roussy, Villejuif
Grand Hôpital de Charleroi, Charleroi
UZ Leuven, Leuven
CHU de Liège, site Sart Tilman, Liège
CHU Ambroise Paré, Mons
CHU UCL Namur site St. Elisabeth, Namur
Hochtaunus-Kliniken, Bad Homburg
Universitätsklinikum Carl Gustav Carus Dresden, Dresden
Kliniken Essen-Mitte, Essen
Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg
Diakovere Krankenhaus, Hanover
Klinikum Kulmbach, Kulmbach
Universitätsklinikum Münster, Münster
MVZ Nordhausen, Nordhausen
Klinikum Oldenburg AöR, Oldenburg
ROMed Klinikum Rosenheim, Rosenheim
Universitätsklinikum Tübingen, Tübingen
Universitätsfrauenklinik Ulm, Ulm
HELIOS Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden
Spedali Civili, Brescia
Asst Lecco, Lecco
Istituto Europeo di Oncologia, Milan
I.R.C.C.S. Istituto Oncologico Veneto, Padua
Arcispedale Santa Maria Nuova, Reggio Emilia
AO Città della Salute e della Scienza- Ospedale Sant'Anna, Torino
Ospedale Mauriziano Umberto I, Torino
Hospital de Sabadell, Sabadell
Complejo Hospitalario Universitario de A Coruña, A Coruña
ICO Badalona, Badalona
H. Clínic Barcelona, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital de la Vall d'Hebron, Barcelona
H Reina Sofía Cordoba, Córdoba
ICO Girona, Girona
ICO Hospitalet, Hospitalet Del Llobregat
Hospital de León, León
Clinica Universitaria de Navarra, Madrid
Hospital Clínico San Carlos, Madrid
Hospital Gregorio Marañon, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Fundación Jiménez Díaz, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Complejo Hospitalario Regional de Málaga, Málaga
H Morales Meseguer, Murcia
Hospital Son Llatzer, Palma de Mallorca
Hospital Virgen del Rocio, Seville
H La Fe de Valencia, Valencia
Hospital Clínico Universitario de Valencia, Valencia
Hospital Universitario Miguel Servet, Zaragoza
Centre Antoine Lacassagne, Nice
Collaborators (1)
Hoffmann-La Roche
INDUSTRY
GlaxoSmithKline
INDUSTRY
AGO Study Group
OTHER
Belgian Gynaecological Oncology Group
OTHER
ARCAGY/ GINECO GROUP
OTHER
Israeli Society of Gynecologic Oncology
OTHER
MaNGO
UNKNOWN
Apices Soluciones S.L.
INDUSTRY
Grupo Español de Investigación en Cáncer de Ovario
OTHER